New Therapeutic Horizons for Graves’ Hyperthyroidism

Graves’ hyperthyroidism is characterized by the presence of autoantibodies that stimulate the thyroid-stimulating hormone receptor (TSHR), resulting in uncontrolled secretion of excessive thyroid hormone. Conventional treatments, including antithyroid medication, radioiodine, or surgery have remaine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lane, Laura C, Cheetham, Tim D, Perros, Petros, Pearce, Simon H S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567404/
https://www.ncbi.nlm.nih.gov/pubmed/32845332
http://dx.doi.org/10.1210/endrev/bnaa022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567404/
https://www.ncbi.nlm.nih.gov/pubmed/32845332
http://dx.doi.org/10.1210/endrev/bnaa022

Ejemplares similares